These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9988497)

  • 1. Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute?
    Casadevall A; Cassone A; Bistoni F; Cutler JE; Magliani W; Murphy JW; Polonelli L; Romani L
    Med Mycol; 1998; 36 Suppl 1():95-105. PubMed ID: 9988497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody immunity and invasive fungal infections.
    Casadevall A
    Infect Immun; 1995 Nov; 63(11):4211-8. PubMed ID: 7591049
    [No Abstract]   [Full Text] [Related]  

  • 3. A novel monoclonal antibody recognizing beta(1-3) glucans in intact cells of Candida and Cryptococcus.
    Kondori N; Edebo L; Mattsby-Baltzer I
    APMIS; 2008 Oct; 116(10):867-76. PubMed ID: 19132980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-mediated protective immunity in fungal infections.
    Magliani W; Conti S; Arseni S; Salati A; Ravanetti L; Maffei DL; Giovati L; Polonelli L
    New Microbiol; 2005 Oct; 28(4):299-309. PubMed ID: 16386014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections.
    Polonelli L; Casadevall A; Han Y; Bernardis F; Kirkland TN; Matthews RC; Adriani D; Boccanera M; Burnie JP; Cassone A; Conti S; Cutler JE; Frazzi R; Gregory C; Hodgetts S; Illidge C; Magliani W; Rigg G; Santoni G
    Med Mycol; 2000; 38 Suppl 1():281-92. PubMed ID: 11204156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Listeria monocytogenes lipids on the immunity of mice against Candida albicans, Cryptococcus neoformans and Trichomonas vaginalis.
    Jakoniuk P; Jabłońska-Strynkowska W; Musiatowicz B; Borowski J
    Arch Immunol Ther Exp (Warsz); 1980; 28(3):377-87. PubMed ID: 6778451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptococcus neoformans: paradigm for the role of antibody immunity against fungi?
    Pirofski LA; Casadevall A
    Zentralbl Bakteriol; 1996 Aug; 284(4):475-95. PubMed ID: 8899968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immune response to fungal infections.
    Shoham S; Levitz SM
    Br J Haematol; 2005 Jun; 129(5):569-82. PubMed ID: 15916679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards a vaccine for Cryptococcus neoformans: principles and caveats.
    Datta K; Pirofski LA
    FEMS Yeast Res; 2006 Jun; 6(4):525-36. PubMed ID: 16696648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain.
    Wormley FL; Cox GM; Perfect JR
    Microb Pathog; 2005; 38(2-3):113-23. PubMed ID: 15748813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive immune responses to Candida albicans infection.
    Richardson JP; Moyes DL
    Virulence; 2015; 6(4):327-37. PubMed ID: 25607781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-mediated effects against Cryptococcus neoformans: evidence for interdependency and collaboration between humoral and cellular immunity.
    Vecchiarelli A; Casadevall A
    Res Immunol; 1998; 149(4-5):321-33; discussion 500-3. PubMed ID: 9720950
    [No Abstract]   [Full Text] [Related]  

  • 13. Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans.
    Capodicasa C; Chiani P; Bromuro C; De Bernardis F; Catellani M; Palma AS; Liu Y; Feizi T; Cassone A; Benvenuto E; Torosantucci A
    Plant Biotechnol J; 2011 Sep; 9(7):776-87. PubMed ID: 21265996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan.
    Maitta RW; Datta K; Pirofski LA
    Vaccine; 2004 Sep; 22(29-30):4062-8. PubMed ID: 15364457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage autophagy in immunity to Cryptococcus neoformans and Candida albicans.
    Nicola AM; Albuquerque P; Martinez LR; Dal-Rosso RA; Saylor C; De Jesus M; Nosanchuk JD; Casadevall A
    Infect Immun; 2012 Sep; 80(9):3065-76. PubMed ID: 22710871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS; Ashman RB
    Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host defence mechanisms against fungal infection.
    Fukazawa Y; Kagaya K
    Microbiol Sci; 1988 Apr; 5(4):124-7. PubMed ID: 3079227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response to Cryptococcus neoformans proteins in rodents and humans.
    Chen LC; Goldman DL; Doering TL; Pirofski La; Casadevall A
    Infect Immun; 1999 May; 67(5):2218-24. PubMed ID: 10225877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced humoral immunity and vaccination against major human fungal pathogens.
    Casadevall A; Feldmesser M; Pirofski LA
    Curr Opin Microbiol; 2002 Aug; 5(4):386-91. PubMed ID: 12160857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of immunity in fungal infections.
    Chute HL
    Am J Vet Res; 1975 Apr; 36(4 Pt 2):601-2. PubMed ID: 1092228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.